497 related articles for article (PubMed ID: 35051888)
1. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
[TBL] [Abstract][Full Text] [Related]
2. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
Front Immunol; 2021; 12():769204. PubMed ID: 34880865
[TBL] [Abstract][Full Text] [Related]
3. Full high-throughput sequencing analysis of differences in expression profiles of long noncoding RNAs and their mechanisms of action in systemic lupus erythematosus.
Ye H; Wang X; Wang L; Chu X; Hu X; Sun L; Jiang M; Wang H; Wang Z; Zhao H; Yang X; Wang J
Arthritis Res Ther; 2019 Mar; 21(1):70. PubMed ID: 30836987
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of long non-coding RNAs and messenger RNA expression profiles in systemic lupus erythematosus.
Luo Q; Li X; Xu C; Zeng L; Ye J; Guo Y; Huang Z; Li J
Mol Med Rep; 2018 Mar; 17(3):3489-3496. PubMed ID: 29286106
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
[TBL] [Abstract][Full Text] [Related]
6. NR_103776.1 as a novel diagnostic biomarker for systemic lupus erythematosus.
Wang Y; He J; Ma H; Liu J; Du L; Chai C; Liu Y; Wang X
Ir J Med Sci; 2024 Feb; 193(1):211-221. PubMed ID: 37369931
[TBL] [Abstract][Full Text] [Related]
7. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus.
Wu GC; Hu Y; Guan SY; Ye DQ; Pan HF
Biomolecules; 2019 May; 9(6):. PubMed ID: 31141998
[TBL] [Abstract][Full Text] [Related]
8. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus.
Li LJ; Zhao W; Tao SS; Li J; Xu SZ; Wang JB; Leng RX; Fan YG; Pan HF; Ye DQ
Cell Immunol; 2017 Sep; 319():17-27. PubMed ID: 28622785
[TBL] [Abstract][Full Text] [Related]
11. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
[TBL] [Abstract][Full Text] [Related]
12. Study on the expression changes of lncRNA in patients with systemic lupus erythematosus and its correlation with Treg cells.
Bu YJ; Cen X; Wang YQ; Fan R; Zhang F; Liu YQ; An J; Qiao J; Zhang SX; Chen JW
Clin Rheumatol; 2024 Mar; 43(3):993-1002. PubMed ID: 38253780
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of lncRNAs N
Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
[TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
15. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Wu J; Cai Y; Zhao G; Li M
J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
[TBL] [Abstract][Full Text] [Related]
16. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
Zhang S; Shao Y; Li D; Li C
Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs.
Steponaitis G; Stakaitis R; Valiulyte I; Krusnauskas R; Dragunaite R; Urbanavičiūtė R; Tamasauskas A; Skiriute D
Sci Rep; 2022 Mar; 12(1):5431. PubMed ID: 35361860
[TBL] [Abstract][Full Text] [Related]
18. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.
Guo G; Wang H; Shi X; Ye L; Wu K; Lin K; Ye S; Li B; Zhang H; Lin Q; Ye S; Xue X; Chen C
J Transl Med; 2018 Dec; 16(1):370. PubMed ID: 30577810
[TBL] [Abstract][Full Text] [Related]
19. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
[TBL] [Abstract][Full Text] [Related]
20. Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses.
Zhao X; Ge L; Wang J; Song Z; Ni B; He X; Ruan Z; You Y
Front Immunol; 2021; 12():752736. PubMed ID: 35197962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
